News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Neuromodulation Systems Inc. Receives Australian Regulatory And Reimbursement Approval For Rechargeable Chronic Pain System



10/3/2006 11:03:26 AM

PLANO, Texas & SYDNEY, Australia--(BUSINESS WIRE)--Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc. (NYSE:STJ), today announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon™ Rechargeable Neurostimulation System. In Australia, the Eon system is fully reimbursable via the private health system.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES